Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
90
-
Total shares
-
29.1M
-
Shares change
-
+5.59M
-
Total reported value, excl. options
-
$209M
-
Value change
-
+$47M
-
Put/Call ratio
-
1.42
-
Number of buys
-
66
-
Number of sells
-
-37
-
Price
-
$7.20
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q2 2018
96 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q2 2018.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.1M shares
.
Largest 10 shareholders include STATE STREET CORP (7.23M shares), BlackRock Inc. (6.04M shares), VANGUARD GROUP INC (4.5M shares), D. E. Shaw & Co., Inc. (1.01M shares), NORTHERN TRUST CORP (1M shares), GEODE CAPITAL MANAGEMENT, LLC (772K shares), WELLS FARGO & COMPANY/MN (612K shares), Intellectus Partners, LLC (557K shares), DEUTSCHE BANK AG\ (466K shares), and MORGAN STANLEY (459K shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.